1-Methylnicotinamide: A Potent Anti-inflammatory Agent Of Vitamin Origin
| Effect | Increase |
| Trial Design | Double blind |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 175 |
| Sex | n/a |
Twice daily topical application of a cream containing the nicotinamide metabolite known as 1-methylnicotinamide (at 0.1-0.5%) in subjects with either acne vulgaris or eczema over the course of 1-3 weeks noted significantly more beneficial responses when compared to placebo cream.
Subjects who had visible burns appeared to see benefits with MNA relative to placebo.
